AI-generated summary
The authors report on 336 children with myopia or reduced hyperopia reserve treated twice daily for three minutes with a head-mounted 650 nm red-light device over three months. Average axial length decreased by 0.031 mm, and differences by sex were not statistically significant. The authors describe the therapy as potentially efficient and feasible, and report no obvious side effects.
- Participants
- 336
- Who or what was studied
- Children who visited a hospital due to myopia or significant decreases in hyperopia reserve, enrolled between June 2022 and April 2023.
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract does not describe a control group, so the observed changes cannot be attributed to the therapy alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.